Athanese Lavidas is Director at ARIAD PHARMACEUTICALS INC (ARIA). They have made 5 open-market trades across 1 company since 2012, most recently 2016-06-15.
CIK 0000884731
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ARIA | 131,631 | $3.4M |
Shares reported on the most recent Form 4, priced at the 2016-06-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ARIA | SELL | 2016-06-15 | 2016-06-15 | $8.24 | $381K | -16.7% | -11.9% | +31.5% |
| ARIA | SELL | 2016-06-14 | 2016-06-15 | $8.14 | $163K | -16.7% | -11.9% | +31.5% |
| ARIA | SELL | 2016-06-13 | 2016-06-15 | $8.21 | $708K | -16.7% | -11.9% | +31.5% |
| ARIA | SELL | 2016-06-13 | 2016-06-15 | $8.21 | $82K | -16.7% | -11.9% | +31.5% |
| ARIA | SELL | 2012-12-21 | 2012-12-27 | $20.31 | $213K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-07-20 | 2012-07-23 | $18.00 | $90K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-06-20 | 2012-06-22 | $17.41 | $87K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-06-05 | 2012-06-07 | $16.05 | $401K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-05-21 | 2012-05-23 | $16.54 | $83K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-04-20 | 2012-04-24 | $15.06 | $151K | -13.2% | +0.2% | +0.2% |
| ARIA | SELL · 10b5-1 | 2012-04-09 | 2012-04-11 | $15.76 | $236K | -13.2% | +0.2% | +0.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.